Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;20(1):5.
doi: 10.1186/1560-8115-20-5. Epub 2012 Jul 19.

Biochemical tolerance during low dose propylene glycol exposure in neonates: A formulation-controlled evaluation

Aida Kulo  1 , Anne Smits, Gunnar Naulaers, Jan de Hoon, Karel Allegaert
Affiliations

Biochemical tolerance during low dose propylene glycol exposure in neonates: A formulation-controlled evaluation

Aida Kulo et al. Daru. 2012.

Abstract

Background and purpose of the study: Propylene glycol (PG) is a frequently co-administered solvent in formulations administered to neonates, but reports on its (in)tolerance are limited. We aimed to report on renal, metabolic and hepatic tolerance before, during and following intravenous (iv) PG-paracetamol exposure and compared these data with similar datasets reported in literature on neonates exposed to PG without paracetamol or paracetamol without PG.

Methods: Renal (diuresis, creatinemia, sodium), metabolic (Base Excess, Anion Gap, lactate, bicarbonate) and hepatic (liver enzymes, bilirubinemia) indicators before, during and following iv paracetamol-PG exposure in neonates as included in the PARANEO (paracetamol in neonates) study (intra-individual trends, ANOVA) were collected and analysed. Comparison with observations collected in cases exposed to either iv phenobarbital-PG or iv paracetamol-mannitol (inter-individual comparison, Mann Whitney-U test) were made.

Results: PG exposure (median 34.1 mg/kg/24 h) did not affect postnatal renal, metabolic and hepatic adaptations in 60 cases exposed to paracetamol-PG. These indicators were similar when compared to 29 cases exposed to phenobarbital-PG or 172 cases exposed to paracetamol-mannitol.

Major conclusion: Based on observations in 89 neonates, low dose PG exposure was tolerated well. Studies on PG pharmacokinetics and its covariates are needed to estimate the upper level of PG tolerance in neonates.

Keywords: Excipient; Formulation; Propylene glycol; Safety; Solvent; Tolerance.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving iv benzodiazepines: a case series and prospective, observational pilot study. Chest. 2005;128:1674–1681. doi: 10.1378/chest.128.3.1674. - DOI - PubMed
    1. Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial. 2007;20:217–219. doi: 10.1111/j.1525-139X.2007.00280.x. - DOI - PubMed
    1. Speth PA, Vree TB, Neilen NF, de Mulder PH, Newell DR, Gore ME, de Pauw BE. Propylene glycol pharmacokinetics and effects after intravenous infusion in humans. Ther Drug Monit. 1987;9:255–258. doi: 10.1097/00007691-198709000-00001. - DOI - PubMed
    1. Nelsen JL, Haas CE, Habtemariam B, Kaufman DC, Partridge A, Welle S, Forrest A. A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients. J Intensive Care Med. 2008;23:184–194. doi: 10.1177/0885066608315808. - DOI - PubMed
    1. Yahwak JA, Riker RR, Fraser GL, Subak-Sharpe S. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy. 2008;28:984–991. doi: 10.1592/phco.28.8.984. - DOI - PubMed